News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PuriCore Board Changes



6/23/2014 8:44:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

23 June 2014 – PuriCore plc (LSE: PURI), a global company focused on safe and effective protection against the spread of infectious pathogens, today announces that Charles Spicer, Non-Executive Director, has been appointed Non-Executive Chairman with effect from today. Michael Ashton will continue to serve as Executive Director and Chief Executive Officer.

Michael Ashton, Chief Executive Officer, said:
“This is an exciting phase for PuriCore as we embark upon a strategic review of our businesses following the sale of the Endoscopy division. I look forward to continuing to work with Charles and the rest of the Board to advance shareholder value.”

Enquiries:
UK
FTI Consulting
Mo Noonan/Simon Conway
Victoria Foster Mitchell
+44 203 727 1000

US Sage Strategic Marketing
Jennifer Guinan
+1 610.410.8111
jennifer@sagestrat.com

About PuriCore
PuriCore plc (LSE: PURI) is a global company focused on safe and effective protection against the spread of infectious pathogens without causing harm to human or animal health or to the environment. PuriCore’s antimicrobial technology and complementary products are used in well-established core businesses and emerging sectors of two broad markets: Health Sciences and Food & Agriculture. In the Health Sciences market, PuriCore is the leading full provider of all products and services required for a safe, efficient, and compliant endoscope decontamination to protect patients and staff in UK hospitals. PuriCore’s breakthrough wound care technology is used to treat chronic and acute wounds including diabetic ulcers and burns in humans, for atopic dermatitis as private-labelled dermatologic treatments for humans, and to manage wounds in all species of companion and farm animals in the animal health segment. In the Food & Agriculture market, PuriCore’s portfolio is used by three of the top-five US supermarket retailers to provide savings in labour costs and improvements in inventory loss and to address cross contamination of pathogens on fresh produce and floral products. In addition, the Company is progressing its research and development programmes on the use of its technology as an agricultural fungicide. PuriCore is headquartered in Malvern, Pennsylvania, with operations in Stafford and Clevedon, UK. To receive additional information on PuriCore, visit www.puricore.com.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
PuriCore
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES